| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 399 | 409 | 393 | 374 | 432 | 440 | 415 | 387 | 448 | 370 | 434 | 434 | 558 | 418 | 442 | 454 | 528 | 427 | 480 | 426 | 398 | 437 | 509 | 483 | 499 | 530 | 590 | 543 | 552 | 610 | 672 | 628 | 623 | 704 | 746 | 688 | 673 | 756 | 746 | 718 |
| Expenses | 362 | 346 | 340 | 320 | 366 | 358 | 348 | 333 | 386 | 326 | 359 | 362 | 428 | 357 | 366 | 375 | 435 | 361 | 396 | 355 | 352 | 356 | 417 | 397 | 448 | 462 | 519 | 478 | 490 | 537 | 579 | 528 | 526 | 570 | 597 | 559 | 552 | 608 | 595 | 589 |
| EBITDA | 37 | 63 | 53 | 53 | 66 | 82 | 67 | 53 | 63 | 44 | 75 | 72 | 129 | 62 | 76 | 79 | 93 | 67 | 84 | 71 | 45 | 81 | 91 | 86 | 51 | 68 | 71 | 65 | 63 | 73 | 93 | 100 | 97 | 134 | 149 | 129 | 121 | 147 | 151 | 130 |
| Operating Profit % | 9 % | 14 % | 13 % | 14 % | 15 % | 18 % | 15 % | 13 % | 14 % | 11 % | 16 % | 16 % | 17 % | 14 % | 16 % | 16 % | 16 % | 15 % | 17 % | 16 % | 10 % | 18 % | 17 % | 17 % | 10 % | 12 % | 11 % | 11 % | 10 % | 10 % | 12 % | 14 % | 15 % | 17 % | 18 % | 18 % | 16 % | 18 % | 19 % | 16 % |
| Depreciation | 8 | 7 | 7 | 7 | 10 | 7 | 7 | 7 | 8 | 8 | 7 | 8 | 8 | 7 | 7 | 7 | 10 | 13 | 13 | 13 | 14 | 13 | 13 | 14 | 15 | 14 | 14 | 14 | 15 | 13 | 13 | 12 | 12 | 12 | 12 | 13 | 13 | 13 | 14 | 14 |
| Interest | 3 | 16 | 15 | 15 | 15 | 16 | 16 | 14 | 10 | 10 | 12 | 12 | 14 | 9 | 9 | 8 | 9 | 8 | 8 | 9 | 8 | 6 | 5 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Profit Before Tax | 31 | 40 | 31 | 31 | 41 | 60 | 43 | 32 | 45 | 27 | 56 | 52 | 107 | 45 | 60 | 64 | 74 | 46 | 63 | 49 | 23 | 61 | 73 | 68 | 33 | 50 | 55 | 47 | 45 | 57 | 76 | 84 | 82 | 121 | 135 | 115 | 107 | 132 | 136 | 114 |
| Tax | 4 | 15 | 12 | 12 | 30 | 15 | 12 | 11 | -63 | 2 | 10 | 19 | 31 | 12 | 14 | 12 | 7 | 9 | 9 | 4 | -3 | 11 | 13 | 15 | 6 | 10 | 11 | 9 | 8 | 9 | 11 | 17 | 23 | 25 | 31 | 24 | 29 | 31 | 31 | 26 |
| Net Profit | 27 | 25 | 19 | 19 | 11 | 45 | 31 | 21 | 107 | 24 | 46 | 33 | 76 | 34 | 46 | 51 | 67 | 37 | 54 | 45 | 27 | 50 | 60 | 53 | 27 | 40 | 44 | 38 | 37 | 48 | 65 | 67 | 59 | 96 | 104 | 91 | 78 | 102 | 105 | 87 |
| EPS in ₹ | 1.49 | 1.42 | 1.10 | 1.11 | 0.60 | 2.48 | 1.71 | 1.14 | 5.91 | 1.34 | 2.52 | 1.81 | 4.18 | 0.97 | 1.32 | 1.44 | 1.89 | 1.07 | 1.52 | 1.27 | 0.78 | 1.42 | 1.70 | 1.51 | 0.80 | 1.12 | 1.21 | 1.05 | 1.03 | 1.32 | 1.76 | 1.84 | 1.61 | 2.62 | 2.84 | 2.48 | 2.13 | 2.77 | 2.86 | 2.38 |
Jyothy Laboratories
333.00
-9.40
(-2.75%)
There are 2 new updates from the company1 day ago
View
Market Cap
12,228.05 Cr
EPS
10.06
PE Ratio
33.77
Dividend Yield
1.02 %
Industry
Consumer Goods52 Week High
595.85
52 Week Low
310.20
PB Ratio
6.67
Debt to Equity
0.03
Sector
Household Products
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from11 analysts
Company News
View All News
Jyothy Labs to Sell Entire Stake in Bangladesh SubsidiaryToday
Jyothy Labs' board has approved the sale of the company's entire equity stake in its subsidiary, Jyothy Kallol Bangladesh. This decision represents a significant corporate action that will likely impact the company's operations and financial structure in Bangladesh.
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
| 333.00 | 12,228.05 | 33.77 | 2,810.70 | 11.29 | 369 | -3.85 | 43.63 | |
| 304.30 | 2,211.87 | 27.73 | 1,317.20 | -1.43 | 67 | 55.95 | 43.76 | |
| 646.85 | 663.56 | 2.27 | 20.30 | 156.96 | 266 | -72.70 | 55.23 | |
| 487.65 | 437.15 | 45.62 | 81.60 | -12.82 | 17 | -78.79 | 50.50 | |
| 431.65 | 323.74 | 2.73 | 650.70 | 12.68 | 15 | -308.62 | 42.16 | |
| 361.10 | 270.83 | 23.42 | 295.50 | 14.98 | 12 | -46.67 | 49.29 | |
| 191.84 | 210.00 | 3.37 | 70.30 | -8.58 | -196 | -28.06 | 47.99 | |
| 593.70 | 157.31 | 13.33 | 134.20 | 7.27 | 10 | 7.14 | 55.30 | |
| 12.70 | 115.13 | 29.43 | 19.80 | -1.98 | -0 | 2,400.00 | 72.82 | |
| 27.56 | 47.34 | 17.66 | 117.20 | - | 1 | -109.38 | 48.52 |
Growth Rate
Revenue Growth
11.29 %
Net Income Growth
54.07 %
Cash Flow Change
39.33 %
ROE
31.95 %
ROCE
33.44 %
EBITDA Margin (Avg.)
34.90 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 1,817 | 1,770 | 1,853 | 1,979 | 1,942 | 1,836 | 1,956 | 2,023 | 2,062 | 2,401 |
| Fixed Assets | 1,074 | 1,068 | 1,097 | 1,091 | 1,101 | 1,149 | 1,147 | 1,122 | 1,116 | 1,125 |
| Current Assets | 546 | 456 | 481 | 663 | 622 | 449 | 625 | 724 | 775 | 1,139 |
| Capital Work in Progress | 16 | 8 | 9 | 15 | 14 | 25 | 10 | 8 | 16 | 13 |
| Investments | 192 | 86 | 29 | 113 | 104 | 0 | 0 | 0 | 0 | 192 |
| Other Assets | 535 | 608 | 719 | 760 | 723 | 663 | 799 | 893 | 930 | 1,071 |
| Total Liabilities | 1,817 | 1,770 | 1,853 | 1,979 | 1,942 | 1,836 | 1,956 | 2,023 | 2,062 | 2,401 |
| Current Liabilities | 411 | 805 | 742 | 811 | 586 | 545 | 473 | 521 | 406 | 481 |
| Non Current Liabilities | 625 | 66 | 29 | 38 | 51 | 92 | 93 | 99 | 104 | 110 |
| Total Equity | 781 | 899 | 1,082 | 1,130 | 1,305 | 1,200 | 1,391 | 1,403 | 1,551 | 1,810 |
| Reserve & Surplus | 762 | 883 | 1,071 | 1,126 | 1,290 | 1,192 | 1,392 | 1,407 | 1,512 | 1,772 |
| Share Capital | 18 | 18 | 18 | 18 | 37 | 37 | 37 | 37 | 37 | 37 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 123 | -2 | 16 | 23 | 13 | -60 | 57 | 4 | 30 | -21 |
| Investing Activities | -26 | 108 | -17 | -74 | 30 | 73 | -129 | -32 | -48 | -344 |
| Operating Activities | 166 | 192 | 163 | 242 | 302 | 172 | 402 | 203 | 329 | 458 |
| Financing Activities | -18 | -302 | -130 | -145 | -319 | -304 | -216 | -167 | -251 | -135 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 16.43 % | 15.10 % | 15.10 % | 14.35 % |
| DIIs | 16.23 % | 15.95 % | 15.53 % | 17.12 % | 15.69 % | 16.93 % | 16.26 % | 17.14 % | 16.82 % | 15.36 % | 13.94 % | 13.66 % | 13.29 % | 14.36 % | 15.27 % | 15.26 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 6.38 % | 7.21 % | 7.09 % | 7.48 % | 8.09 % | 6.38 % | 5.88 % | 5.71 % | 5.60 % | 6.62 % | 6.87 % | 7.11 % | 6.07 % | 6.34 % | 5.91 % | 6.61 % |
| Others | 14.50 % | 13.95 % | 14.49 % | 12.51 % | 13.33 % | 13.80 % | 14.97 % | 14.27 % | 14.69 % | 15.13 % | 16.30 % | 16.35 % | 1.32 % | 1.31 % | 0.83 % | 0.89 % |
| No of Share Holders | 0 | 1,18,542 | 1,29,673 | 1,38,449 | 1,48,329 | 1,46,657 | 1,38,767 | 1,33,207 | 1,26,618 | 1,27,003 | 1,39,188 | 1,63,880 | 1,50,093 | 1,59,996 | 1,63,046 | 1,94,753 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 6 | 0.5 | 3 | 3 | 4 | 2.5 | 3 | 3.5 | 0.00 |
| Dividend Yield (%) | 0.00 | 3.03 | 0.27 | 3.25 | 2.19 | 2.71 | 1.32 | 0.68 | 1.02 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement Under Regulation 30
Board Meeting Outcome for Board Meeting Outcome Without Intimation
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011
Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement Under Regulation 30 (LODR)- Product Launch
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Integrated Filing (Financial)
Announcement Under Regulation 30 (LODR)- Product Launch
Announcement under Regulation 30 (LODR)-Investor Presentation
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024
Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024
Disclosure Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Board Meeting Intimation for Notice Of The Board Meeting To Consider And Approve Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended December 31 2024.
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Technical Indicators
RSI(14)
Neutral 48.59
ATR(14)
Volatile 12.99
STOCH(9,6)
Neutral 72.47
STOCH RSI(14)
Overbought 91.69
MACD(12,26)
Bullish 3.63
ADX(14)
Weak Trend 24.95
UO(9)
Bearish 52.85
ROC(12)
Uptrend But Slowing Down 2.27
WillR(14)
Neutral -23.45
About Jyothy Laboratories
Jyothy Laboratories Ltd is an FMCG company founded in 1983 and incorporated in 1992. It manufactures and markets products in fabric care, dishwashing, household insecticides, and personal care categories. The company operates 25 manufacturing plants across 21 locations in India, with several ISO 9001-2015 certified units. Jyothy Labs' products are available in over 2.8 million outlets through various distribution channels. The company is divided into segments including Fabric Care, Dishwashing, Household Insecticides, Personal Care, and Others. Key brands include Ujala, Maxo, Exo, Margo, and Henko. The company has expanded through acquisitions, joint ventures, and product launches. In 2023, it merged with its wholly-owned subsidiary Jyothy Fabricare Services Limited. Jyothy Kallol Bangladesh Limited is a subsidiary of the company.
Listing Date
19 Dec, 2007(17 Years,
34 days)
Chairperson NameM R Jyothy
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
